|
APEX2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.470800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.971600E-01 |
| Normal-vs-Stage2 |
1.101960E-02 |
| Normal-vs-Stage3 |
4.987600E-01 |
| Normal-vs-Stage4 |
1.960580E-01 |
| Stage1-vs-Stage2 |
4.916000E-02 |
| Stage1-vs-Stage3 |
3.067800E-01 |
| Stage1-vs-Stage4 |
6.996500E-02 |
| Stage2-vs-Stage3 |
4.908300E-02 |
| Stage2-vs-Stage4 |
3.019800E-03 |
| Stage3-vs-Stage4 |
8.658600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.699600E-01 |
| Normal-vs-AfricanAmerican |
4.114800E-01 |
| Normal-vs-Asian |
3.769600E-01 |
| Caucasian-vs-AfricanAmerican |
4.195400E-01 |
| Caucasian-vs-Asian |
5.075400E-01 |
| AfricanAmerican-vs-Asian |
2.744800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.803200E-01 |
| Normal-vs-Female |
8.406600E-01 |
| Male-vs-Female |
8.405000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.357200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.902000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.079000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.890600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.210400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.823800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.999200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.657200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.476600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.817600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.852000E-01 |
| Normal-vs-Grade 2 |
2.126000E-01 |
| Normal-vs-Grade 3 |
9.514000E-01 |
| Normal-vs-Grade 4 |
2.626000E-02 |
| Grade 1-vs-Grade 2 |
3.032800E-01 |
| Grade 1-vs-Grade 3 |
9.377200E-01 |
| Grade 1-vs-Grade 4 |
7.622200E-02 |
| Grade 2-vs-Grade 3 |
3.799400E-01 |
| Grade 2-vs-Grade 4 |
1.659110E-03 |
| Grade 3-vs-Grade 4 |
7.413500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.059700E-03 |
| Normal-vs-ccB subtype |
1.254770E-01 |
| ccA subtype-vs-ccB subtype |
2.519300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.421000E-01 |
| Normal-vs-N1 |
3.988500E-02 |
| N0-vs-N1 |
7.218000E-02 |
|
|
